Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Bioactive peptides and proteins as alternative antiplatelet drugs

KRR. Rengasamy, H. Khan, I. Ahmad, D. Lobine, F. Mahomoodally, S. Suroowan, STS. Hassan, S. Xu, S. Patel, M. Daglia, SM. Nabavi, SK. Pandian,

. 2019 ; 39 (6) : 2153-2171. [pub] 20190422

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025548

Grantová podpora
18CDA34110359 American Heart Association-American Stroke Association - United States

Antiplatelet drugs reduce the risks associated with atherothrombotic events and show various applications in diverse cardiovascular diseases including myocardial infarctions. Efficacy of the current antiplatelet medicines including aspirin, clopidogrel, prasugrel and ticagrelor, and the glycoprotein IIb/IIIa antagonists, are limited due to their increased risks of bleeding, and antiplatelet drug resistance. Hence, it is important to develop new effective antiplatelet drugs, with fewer side-effects. The vast repertoire of natural peptides can be explored towards this goal. Proteins and peptides derived from snake venoms and plants represent exciting candidates for the development of novel and potent antiplatelet agents. Consequently, this review discusses multiple peptides that have displayed antiplatelet aggregation activity in preclinical drug development stages. This review also describes the antiplatelet mechanisms of the peptides, emphasizing the signaling pathways intervened by them. Also, the hurdles encountered during the development of peptides into antiplatelet drugs have been listed. Finally, hitherto unexplored peptides with the potential to prevent platelet aggregation are explored.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025548
003      
CZ-PrNML
005      
20201222155246.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/med.21579 $2 doi
035    __
$a (PubMed)31006878
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rengasamy, Kannan R R $u Department of Biotechnology, Alagappa University, Karaikudi, India.
245    10
$a Bioactive peptides and proteins as alternative antiplatelet drugs / $c KRR. Rengasamy, H. Khan, I. Ahmad, D. Lobine, F. Mahomoodally, S. Suroowan, STS. Hassan, S. Xu, S. Patel, M. Daglia, SM. Nabavi, SK. Pandian,
520    9_
$a Antiplatelet drugs reduce the risks associated with atherothrombotic events and show various applications in diverse cardiovascular diseases including myocardial infarctions. Efficacy of the current antiplatelet medicines including aspirin, clopidogrel, prasugrel and ticagrelor, and the glycoprotein IIb/IIIa antagonists, are limited due to their increased risks of bleeding, and antiplatelet drug resistance. Hence, it is important to develop new effective antiplatelet drugs, with fewer side-effects. The vast repertoire of natural peptides can be explored towards this goal. Proteins and peptides derived from snake venoms and plants represent exciting candidates for the development of novel and potent antiplatelet agents. Consequently, this review discusses multiple peptides that have displayed antiplatelet aggregation activity in preclinical drug development stages. This review also describes the antiplatelet mechanisms of the peptides, emphasizing the signaling pathways intervened by them. Also, the hurdles encountered during the development of peptides into antiplatelet drugs have been listed. Finally, hitherto unexplored peptides with the potential to prevent platelet aggregation are explored.
650    _2
$a zvířata $7 D000818
650    _2
$a dietní proteiny $x terapeutické užití $7 D004044
650    _2
$a preklinické hodnocení léčiv $7 D004353
650    _2
$a lidé $7 D006801
650    _2
$a peptidy $x farmakokinetika $x terapeutické užití $7 D010455
650    _2
$a rostliny $x chemie $7 D010944
650    _2
$a inhibitory agregace trombocytů $x terapeutické užití $7 D010975
650    _2
$a proteiny $x terapeutické užití $7 D011506
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Khan, Haroon $u Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan, Pakistan.
700    1_
$a Ahmad, Imad $u Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan, Pakistan.
700    1_
$a Lobine, Devina $u Department of Health Sciences, Faculty of Science, University of Mauritius, Réduit, Mauritius.
700    1_
$a Mahomoodally, Fawzi $u Department of Health Sciences, Faculty of Science, University of Mauritius, Réduit, Mauritius.
700    1_
$a Suroowan, Shanoo $u Department of Health Sciences, Faculty of Science, University of Mauritius, Réduit, Mauritius.
700    1_
$a Hassan, Sherif T S $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
700    1_
$a Xu, Suowen $u Aab Cardiovascular Research Institute, University of Rochester, Rochester, New York.
700    1_
$a Patel, Seema $u Bioinformatics and Medical Informatics Research Center, San Diego State University, San Diego, California.
700    1_
$a Daglia, Maria $u Department of Drug Sciences, Medicinal Chemistry and Pharmaceutical Technology Section, Pavia University, Pavia, Italy.
700    1_
$a Nabavi, Seyed Mohammad $u Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
700    1_
$a Pandian, Shunmugiah Karutha $u Department of Biotechnology, Alagappa University, Karaikudi, India.
773    0_
$w MED00003265 $t Medicinal research reviews $x 1098-1128 $g Roč. 39, č. 6 (2019), s. 2153-2171
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31006878 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222155242 $b ABA008
999    __
$a ok $b bmc $g 1599693 $s 1116234
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 39 $c 6 $d 2153-2171 $e 20190422 $i 1098-1128 $m Medicinal research reviews $n Med Res Rev $x MED00003265
GRA    __
$a 18CDA34110359 $p American Heart Association-American Stroke Association $2 United States
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace